Chest CT findings may help predict outcomes of SBRT in stage I lung cancer
Leesburg: Imaging findings on chest CT conducted before a patient undergoes stereotactic body radiation therapy (SBRT) for stage I lung cancer may help predict treatment outcome. Noncancerous imaging markers on chest CT performed before stereotactic body radiation therapy (SBRT) improve survival prediction, compared with clinical features alone, finds a new study.
The study has been published in the American Journal of Roentgenology (AJR).
"In patients undergoing SBRT for stage I lung cancer," explained corresponding author and 2019 ARRS Scholar Florian J. Fintelmann, "higher coronary artery calcium (CAC) score, higher pulmonary artery (PA)-to-aorta ratio, and lower thoracic skeletal muscle index independently predicted worse overall survival."
Fintelmann and team's retrospective study included 282 patients (168 female, 114 male; median age, 75 years) with stage I lung cancer treated with SBRT between January 2009 and June 2017. To quantify CAC score and PA-to-aorta ratio, as well as emphysema and body composition, pretreatment chest CT was used. Associations of clinical and imaging features with overall were quantified using a multivariable Cox proportional hazards (PH) model.
For stage I lung cancer patients treated with SBRT, CAC score, PA-to-aorta ratio, and skeletal muscle index showed significant independent associations with overall survival. (p<.05). The model including clinical and imaging features demonstrated better discriminatory ability for 5-year overall survival than the model including clinical features alone (AUC 0.75 vs. 0.61, p<.01).
For further information, click on this link:
